Published in Vascular on October 10, 2008
'The use of heparin in patients with ruptured abdominal aortic aneurysms'. Vascular (2013) 0.75
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother (2010) 4.23
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford) (2009) 2.44
Inclusive fitness theory and eusociality. Nature (2011) 2.31
Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis (2011) 1.99
Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol (2003) 1.86
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis (2007) 1.83
Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet (2011) 1.72
Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation (2002) 1.67
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet (2011) 1.60
Developing an education and assessment framework for the Foundation Programme. Med Educ (2005) 1.55
Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest (2011) 1.52
Plant immunostimulants--scientific paradigm or myth? J Ethnopharmacol (2010) 1.49
Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2006) 1.48
Stent-graft limb deployment in the external iliac artery increases the risk of limb occlusion following endovascular AAA repair. J Endovasc Ther (2012) 1.47
Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation (2007) 1.46
Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol (2011) 1.39
Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein. J Biol Chem (2007) 1.37
Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study. Arthritis Rheum (2010) 1.27
Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics (2011) 1.24
Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler Thromb Vasc Biol (2007) 1.18
Empty sites can promote altruistic behavior. Evolution (2008) 1.16
A new imaging method for assessment of aortic dissection using four-dimensional phase contrast magnetic resonance imaging. J Vasc Surg (2012) 1.14
Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. Circulation (2012) 1.14
The monocyte/macrophage as a therapeutic target in atherosclerosis. Curr Opin Pharmacol (2009) 1.14
Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med (2011) 1.13
The role of neovascularisation in the resolution of venous thrombus. Thromb Haemost (2005) 1.07
Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis. Arthritis Res Ther (2011) 1.05
Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood (2002) 1.05
Monocyte recruitment in venous thrombus resolution. J Vasc Surg (2006) 1.01
Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol. Rheumatology (Oxford) (2010) 1.00
A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet (2013) 1.00
Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation (2010) 1.00
TIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limb. EMBO Mol Med (2013) 0.99
Upper limb ischemia: 20 years experience from a single center. Vascular (2005) 0.98
Cysteine protease activity in the wall of abdominal aortic aneurysms. J Vasc Surg (2007) 0.97
Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists. J Immunol Methods (2011) 0.96
Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation (2010) 0.95
3D T(1)-mapping for the characterization of deep vein thrombosis. MAGMA (2009) 0.95
Human tribbles homologue 2 is expressed in unstable regions of carotid plaques and regulates macrophage IL-10 in vitro. Clin Sci (Lond) (2009) 0.95
Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clin Experiment Ophthalmol (2005) 0.95
Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis (2008) 0.95
Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity. J Rheumatol (2009) 0.93
Towards a more relevant hind limb model of muscle ischaemia. Atherosclerosis (2012) 0.92
Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost (2003) 0.92
Hypoxia and upregulation of hypoxia-inducible factor 1{alpha} stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol (2010) 0.92
Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis. J Vasc Surg (2009) 0.92
A new method for quantification of false lumen thrombosis in aortic dissection using magnetic resonance imaging and a blood pool contrast agent. J Vasc Surg (2011) 0.91
Antiangiogenic therapy inhibits venous thrombus resolution. Arterioscler Thromb Vasc Biol (2014) 0.91
Molecular systematics and origin of sociality in mongooses (Herpestidae, Carnivora). Mol Phylogenet Evol (2004) 0.91
Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. J Vasc Surg (2006) 0.90
Priapism secondary to leukemia: effective management with prompt leukapheresis. Int J Urol (2004) 0.90
An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum Mol Genet (2007) 0.90
Mutations in FOXC2 in humans (lymphoedema distichiasis syndrome) cause lymphatic dysfunction on dependency. J Vasc Res (2011) 0.89
The relationship between persistent organic pollutants in maternal and neonatal tissues and immune responses to allergens: A novel exploratory study. Chemosphere (2005) 0.89
A comparison between pre- and posthibernation morphometry, hematology, and blood chemistry in viperid snakes. J Zoo Wildl Med (2003) 0.87
Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers. J Vasc Surg (2003) 0.87
Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Ther Apher Dial (2008) 0.86
The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. Clin Exp Rheumatol (2014) 0.86
Pyelonephritis: what are the present day causative organisms and antibiotic susceptibilities? Nephrology (Carlton) (2013) 0.85
Molecular therapeutic targets in rheumatoid arthritis. Expert Rev Mol Med (2005) 0.85
Incorporating uncertainty of management costs in sensitivity analyses of matrix population models. Conserv Biol (2013) 0.85
Direct, quantitative clinical assessment of hand function: usefulness and reproducibility. Man Ther (2006) 0.85
Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms. Vascular (2006) 0.85
Variation in the use of biologics in the management of rheumatoid arthritis across the UK. Curr Med Res Opin (2012) 0.85
The BEST study--a prospective study to compare business class versus economy class air travel as a cause of thrombosis. S Afr Med J (2003) 0.84
An Australian tuberous sclerosis cohort: are surveillance guidelines being met? J Paediatr Child Health (2011) 0.83
Glycoviruses: chemical glycosylation retargets adenoviral gene transfer. Angew Chem Int Ed Engl (2005) 0.82
Progressive multifocal leucoencephalopathy in a case of chronic lymphocytic leukaemia. Br J Haematol (2005) 0.82
Lymphoedema-distichiasis and FOXC2: unreported mutations, de novo mutation estimate, families without coding mutations. Hum Genet (2005) 0.82